FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
4,454 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-515 | 60923-0515-24 | — |
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-516 | 60923-0516-25 | — |
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-517 | 60923-0517-26 | — |
| Elevidysdelandistrogene moxeparvovec-rokl |
| — |
| KitIntravenous |
| Sarepta Therapeutics, Inc. |
| BLA |
| 60923-518 |
| 60923-0518-27 |
| — |
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-519 | 60923-0519-28 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-520 | 60923-0520-29 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-521 | 60923-0521-30 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-522 | 60923-0522-31 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-523 | 60923-0523-32 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-524 | 60923-0524-33 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-525 | 60923-0525-34 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-526 | 60923-0526-35 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-527 | 60923-0527-36 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-528 | 60923-0528-37 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-529 | 60923-0529-38 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-530 | 60923-0530-39 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-531 | 60923-0531-40 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-532 | 60923-0532-41 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-533 | 60923-0533-42 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-534 | 60923-0534-43 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-535 | 60923-0535-44 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-536 | 60923-0536-45 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-537 | 60923-0537-46 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-538 | 60923-0538-47 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-539 | 60923-0539-48 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-540 | 60923-0540-49 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-541 | 60923-0541-50 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-542 | 60923-0542-51 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-543 | 60923-0543-52 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-544 | 60923-0544-53 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-545 | 60923-0545-54 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-546 | 60923-0546-55 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-547 | 60923-0547-56 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-548 | 60923-0548-57 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-549 | 60923-0549-58 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-550 | 60923-0550-59 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-551 | 60923-0551-60 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-552 | 60923-0552-61 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-553 | 60923-0553-62 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-554 | 60923-0554-63 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-555 | 60923-0555-64 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-556 | 60923-0556-65 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-557 | 60923-0557-66 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-558 | 60923-0558-67 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-559 | 60923-0559-68 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-560 | 60923-0560-69 | — |
|---|
| Elevidysdelandistrogene moxeparvovec-rokl | — | KitIntravenous | Sarepta Therapeutics, Inc. | BLA | 60923-561 | 60923-0561-70 | — |
|---|
| ELF ACNE Fighting Spot Gel with Aloe Clearsalicylic acid | Salicylic acid 1 g/100mL | GelTopical | e.l.f. Cosmetics, Inc | OTC monograph drug | 76354-616 | 76354-0616-01 | — |
|---|
| ELF Blemish Control Face Primer Clearsalicylic acid | Salicylic acid 2 g/100mL | CreamTopical | e.l.f. Cosmetics, Inc | OTC monograph drug | 76354-210 | 76354-0210-10 | — |
|---|
| ELF Clear Blemish Control Face Primersalicylic acid | Salicylic acid 2 g/100mL | CreamTopical | e.l.f. Cosmetics, Inc | OTC monograph drug | 76354-624 | 76354-0624-01 | — |
|---|